Maurine Miner

11PUBLICATIONS
82CO-AUTHORS
NanomedicineInnate immunityGenetic immunologyAtmospheric aerosolsPacific Peoples social, cultural, emotional and spiritual wellbeing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 01, 2026
On the economics of broadly neutralizing monoclonal antibodies for HIV prevention in high-income countries.

|Sep 24, 2026
Relative efficacy, safety and immunogenicity of bivalent versus monovalent COVID-19 mRNA booster vaccines: a randomized trial.

|Apr 03, 2026
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials.

Carolyn Williamson, Chivonne Moodley, Craig A Magaret

|Apr 11, 2025
ALVAC-prime and monomeric gp120 protein boost induces distinct HIV-1 specific humoral and cellular responses compared with adenovirus-prime and trimeric gp140 protein boost.

Leigh H Fisher, Erica Lazarus, Chenchen Yu

|Sep 20, 2024
Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1-2 randomized double-blind placebo-controlled trial.

Vimla Naicker, Fatima Laher, Linda-Gail Bekker

|Mar 19, 2024
Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.

Zoe Moodie, Erica Andersen-Nissen, Nicole Grunenberg

Pageof 2

Frequent Collaborators

7 joint publications

Lawrence Corey

5 joint publications

David Montefiori

4 joint publications

Zoe Moodie

4 joint publications

Fatima Laher